Stockscreener 앱 받기
2.00
10.19%
0.185
시장 영업 전:
1.97
-0.03
-1.50%
전일 마감가:
$1.815
열려 있는:
$1.78
하루 거래량:
203.75K
Relative Volume:
0.03
시가총액:
$1.50M
수익:
-
순이익/손실:
$-11.38M
주가수익비율:
-0.0721
EPS:
-27.73
순현금흐름:
$-12.72M
1주 성능:
-11.11%
1개월 성능:
+1,150%
6개월 성능:
-34.43%
1년 성능:
+395.05%
1일 변동 폭
$1.78
$2.20
1주일 범위
$1.78
$2.283
52주 변동 폭
$0.0915
$14.75
Windtree Therapeutics Inc Stock (WINT) Company Profile
명칭
Windtree Therapeutics Inc
전화
(215) 488-9300
주소
2600 KELLY ROAD, WARRINGTON, PA
WINT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WINT
Windtree Therapeutics Inc
|
2.00 | 1.50M | 0 | -11.38M | -12.72M | -27.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.34 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.16 | 78.51B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
580.43 | 35.27B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
238.74 | 30.91B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
245.71 | 26.37B | 3.32B | -860.46M | -1.04B | -8.32 |
Windtree Therapeutics Inc Stock (WINT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-06-26 | 개시 | Ladenburg Thalmann | Buy |
Windtree Therapeutics Inc 주식(WINT)의 최신 뉴스
FY2024 Earnings Forecast for WINT Issued By Zacks Small Cap - Defense World
Windtree Therapeutics Secures Patent for Istaroxime IV Formulation in Acute Heart Failure - MSN
Windtree (WINT) Sees Pre-Market Surge Following Key Patent Milestone - Stocks Telegraph
SponsoredImpartialComprehensive - Research Tree
Windtree Therapeutics (WINT) Shares Are Volatile: What's Going On? - Benzinga
WINT: Advancing Lead Asset; Leveraging Strategic M&A to Potentially Shorten Timeline to Revenue Generation – Initiating Coverage - Yahoo Finance
WINTWindtree Therapeutics Inc Latest Stock News & Market Updates - StockTitan
Windtree's Heart Failure Treatment Gains Critical Patent ProtectionWhat This Means for AHF Patients - StockTitan
Windtree Therapeutics Files Patent Application in India for Istaroxime, Advancing Arrhythmia Treatment - MSN
Discovery Laboratories Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015 - Marketscreener.com
Comparing Senti Biosciences (NASDAQ:SNTI) and Windtree Therapeutics (NASDAQ:WINT) - Defense World
Windtree Therapeutics, Inc. (NASDAQ:WINT) Sees Large Drop in Short Interest - Defense World
Windtree Files Istaroxime Cardiogenic Shock and Prevention of Arrythmias Patent for India - The Manila Times
Windtree's Cardiac Drug Patent Filing Targets India's Massive MarketPhase 3 Trials on Horizon - StockTitan
Windtree Therapeutics Announces Reverse Stock Split to Maintain Nasdaq Compliance - MSN
Inhibikase Therapeutics (NYSE:IKT) vs. Windtree Therapeutics (NASDAQ:WINT) Critical Survey - Defense World
Windtree Therapeutics, Inc. Announces Reverse Stock Split - GlobeNewswire
Windtree Therapeutics approves 1-for-50 reverse stock split - MSN
Windtree Therapeutics Approves 1-for-50 Reverse Stock Split; Shares Fall Pre-Bell -February 18, 2025 at 09:35 am EST - Marketscreener.com
Windtree Therapeutics Announces Reverse Stock Split Approval - TipRanks
Windtree Therapeutics approves 1-for-50 reverse stock split By Investing.com - Investing.com South Africa
Strategic 1:50 Reverse Split: Windtree's Bold Move to Secure Nasdaq Future - StockTitan
Windtree Therapeutics Highlights Promising Phase 2b Results for Istaroxime - MSN
Windtree Therapeutics, Inc. (NASDAQ:WINT) Sees Significant Drop in Short Interest - Defense World
Windtree reports positive Phase 2b study on heart failure therapy - MSN
Windtree reports positive Phase 2b study on heart failure therapy By Investing.com - Investing.com South Africa
Windtree Announces Special Late-Breaking Clinical Science - GlobeNewswire
Breakthrough Heart Failure Drug Shows Remarkable Safety Profile in Latest Clinical Trial - StockTitan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
The -95.92% Simple Moving Average of Windtree Therapeutics Inc’s (WINT) Stock in the Past 200 Days - The News Heater
Market Watch Highlights: Windtree Therapeutics Inc (WINT) Ends on an Downturn Note at 0.12 - The Dwinnex
Windtree Therapeutics Inc (NASDAQ: WINT) Stock Dropped -60.95% Over A Month – Any Room To Run? - Marketing Sentinel
Windtree Therapeutics enacts reverse stock split, expands equity plan - MSN
WINT: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
WINT (Windtree Therapeutics Inc) may reap gains as insiders became active recently - Knox Daily
It makes sense and dollars to buy Windtree Therapeutics Inc (WINT) stock - SETE News
Windtree Therapeutics enacts reverse stock split, expands equity plan By Investing.com - Investing.com Australia
This morning’s top pick is Windtree Therapeutics Inc (NASDAQ:WINT) - US Post News
Short Interest in Windtree Therapeutics, Inc. (NASDAQ:WINT) Rises By 72.4% - Defense World
Windtree Therapeutics adjusts Series C Preferred Stock terms - MSN
What Did We Find About Insider Trading At Windtree Therapeutics Inc (NASDAQ: WINT)? - Stocks Register
Windtree Therapeutics Announces Offer to Reduce Conversion Price of Series C Preferred Stock - Defense World
Windtree Therapeutics Inc (WINT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.14%
2.83%
자본화:
|
볼륨(24시간):